PHARMCARE 5: a comparison of costs in monetary units WITH OUTCOMES IN QUANTITATIVE NON-MONETARY UNITS, e.g., reduced mortality or morbidity

Question

a comparison of costs in monetary units  WITH OUTCOMES IN QUANTITATIVE NON-MONETARY UNITS, e.g., reduced mortality or  morbidity

LEIGHTON DWIGHT OBILLOS · Accepted Answer

Cost-effectiveness analysis (CEA)

A comparison of costs in monetary units WITH OUTCOMES IN QUANTITATIVE NON-MONETARY UNITS, e.g., reduced mortality or morbidity